NCT06207929

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 18,157 (actual)
• Sponsor: Evidation Health · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this decentralized, observational study is to enroll and observe adults in the contingent United States during the 2023-2024 flu season. The main study objectives are to create a dataset of paired wearable data, self-reported symptoms, and respiratory viral infection (RVI) from PCR testing during the 2023-2024 flu season and to develop algorithm that is able to accurately classify asymptomatic and symptomatic RVI and understand the algorithm's performance metrics.

Conditions

• Influenza, Human
• COVID-19
• Influenza A
• Influenza B
• Respiratory Syncytial Virus (RSV)

Timeline

• Start date: 2024-01-21
• Primary completion: 2024-08-07
• Completion: 2024-08-07
• First posted: 2024-01-17
• Last updated: 2024-09-05

Locations

1 site across 1 country: United States